SAB Biotherapeutics (SABS) Other Non-Current Assets (2020 - 2021)

SAB Biotherapeutics (SABS) has 1 years of Other Non-Current Assets data on file, last reported at $13.1 million in Q4 2021.

• Quarterly Other Non-Current Assets changed N/A year-over-year to $13.1 million in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $13.1 million (changed N/A YoY) and the FY2021 annual result came in at $13.1 million, changed N/A from the prior year.
• Other Non-Current Assets held at $13.1 million in Q4 2021.
• In the past five years, Other Non-Current Assets ranged from a high of $13.1 million in Q4 2021 to a low of $13.1 million in Q4 2021.